Department of Neurology, Bozok University Medical School, Yozgat, Turkey.
Department of Biochemistry, Bozok University Medical School, Yozgat, Turkey.
Mult Scler Relat Disord. 2020 May;40:101946. doi: 10.1016/j.msard.2020.101946. Epub 2020 Jan 16.
Migraine coexistence, which is high in multiple sclerosis (MS), is reported. To better understand the etiology of the coexistence of MS and migraine and the outcomes of this relationship, the vitamin D, vitamin D-binding protein (VITDBP), vitamin D receptor (VITDR), high-sensitivity C-reactive protein (hs-CRP), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), total antioxidant status (TAS), total oxidant status (TOS), and Oxidative Stress Index (OSI) values were examined in patients with the coexistence of relapsing-remitting multiple sclerosis (RRMS) and migraine.
This study was conducted between January 1, 2019, and July 25, 2019, at the neurology and biochemistry clinics of two different tertiary hospitals simultaneously. Overall, 50 RRMS patients with migraine, 50 RRMS patients without migraine, and 50 healthy volunteers were included in the study. The participants' vitamin D, VITDBP, VITDR, hs-CRP, SOD, CAT, GSH-Px, TAS, TOS, and OSI values were measured.
The vitamin D and VITDR values of the RRMS patients with migraine were lower than those of the RRMS patients without migraine (respectively, p = 0.014, p < 0.001). There was no significant difference between the RRMS patients with and without migraine in terms of their VITDBP values (p = 0.570). The SOD, CAT, GSH-Px, and TAS values of the RRMS patients with migraine were lower than those without migraine (all p < 0.001). The hs-CRP and TOS values of the RRMS patients with migraine were higher than those without migraine (all p < 0.001).
To the best of our knowledge, this is the first study on this topic to date. Based on the results, our study may shed light on the etiopathogenesis of the coexistence of MS and migraine and new treatments. However, more studies are needed to better understand the etiology of this relationship and its negative effects.
多发性硬化症(MS)中存在偏头痛共存现象。为了更好地了解 MS 和偏头痛共存的病因以及这种关系的结果,研究检测了伴有复发性缓解型多发性硬化症(RRMS)和偏头痛的患者的维生素 D、维生素 D 结合蛋白(VITDBP)、维生素 D 受体(VITDR)、高敏 C 反应蛋白(hs-CRP)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)、总抗氧化状态(TAS)、总氧化状态(TOS)和氧化应激指数(OSI)值。
这项研究于 2019 年 1 月 1 日至 2019 年 7 月 25 日在两家不同的三级医院的神经内科和生物化学诊所同时进行。共有 50 名伴有偏头痛的 RRMS 患者、50 名无偏头痛的 RRMS 患者和 50 名健康志愿者被纳入研究。测量了参与者的维生素 D、VITDBP、VITDR、hs-CRP、SOD、CAT、GSH-Px、TAS、TOS 和 OSI 值。
伴有偏头痛的 RRMS 患者的维生素 D 和 VITDR 值低于无偏头痛的 RRMS 患者(分别为 p=0.014,p<0.001)。伴有偏头痛和无偏头痛的 RRMS 患者的 VITDBP 值无显著差异(p=0.570)。伴有偏头痛的 RRMS 患者的 SOD、CAT、GSH-Px 和 TAS 值低于无偏头痛的 RRMS 患者(均 p<0.001)。伴有偏头痛的 RRMS 患者的 hs-CRP 和 TOS 值高于无偏头痛的 RRMS 患者(均 p<0.001)。
据我们所知,这是迄今为止关于这一主题的第一项研究。根据研究结果,我们的研究可能为 MS 和偏头痛共存的发病机制以及新的治疗方法提供新的见解。然而,还需要更多的研究来更好地了解这种关系的病因及其负面影响。